Transcriptome analysis identifies key regulators and networks in Acute myeloid leukemia

References

• Slusher TM, Olusanya BO, Vreman HJ, et al. A randomized trial of phototherapy with filtered sunlight in African neonates. N Engl J Med. 2015;373:1115–1124. doi: 10.1056/NEJMoa1501074
   PubMed Web of Science ®Google Scholar
• Trino S, Lamorte D, Caivano A, et al. MicroRNAs as new biomarkers for diagnosis and prognosis, and as potential therapeutic targets in acute myeloid leukemia. Int J Mol Sci. 2018;19:460. doi: 10.3390/ijms19020460
   PubMed Web of Science ®Google Scholar
• Shih AH, Abdel-Wahab O, Patel JP, et al. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer. 2012;12:599–612. doi: 10.1038/nrc3343
   PubMed Web of Science ®Google Scholar
• Vitsios DM, Davis MP, van Dongen S, et al. Large-scale analysis of microRNA expression, epi-transcriptomic features and biogenesis. Nucleic Acids Res. 2017;45:1079–1090. doi: 10.1093/nar/gkw1031
   PubMed Web of Science ®Google Scholar
• Wallace JA, O'Connell RM. MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts. Blood. 2017;130:1290–1301. doi: 10.1182/blood-2016-10-697698
   PubMed Web of Science ®Google Scholar
• Pichiorri F, De Luca L, Aqeilan RI. MicroRNAs: new players in multiple myeloma. Front Genet. 2011;2:22. doi: 10.3389/fgene.2011.00022
   PubMedGoogle Scholar
• Mathews CK. Deoxyribonucleotide metabolism, mutagenesis and cancer. Nat Rev Cancer. 2015;15:528–539. doi: 10.1038/nrc3981
   PubMed Web of Science ®Google Scholar
• Sylwestrowicz T, Piga A, Murphy P, et al. The effect of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells. Br J Haematol. 1982;51:623–630. doi: 10.1111/j.1365-2141.1982.tb02826.x
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang Z, Li Y, et al. PBX3 is an important cofactor of HOXA9 in leukemogenesis. Blood. 2013;121:1422–1431. doi: 10.1182/blood-2012-07-442004
   PubMed Web of Science ®Google Scholar
• Dickson GJ, Liberante FG, Kettyle LM, et al. HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy. Haematologica. 2013;98:1216–1225. doi: 10.3324/haematol.2012.079012
   PubMed Web of Science ®Google Scholar
• Chinen Y, Taki T, Tsutsumi Y, et al. The leucine twenty homeobox (LEUTX) gene, which lacks a histone acetyltransferase domain, is fused to KAT6A in therapy-related acute myeloid leukemia with t(8;19)(p11;q13). Genes Chromosomes Cancer. 2014;53:299–308. doi: 10.1002/gcc.22140
   PubMed Web of Science ®Google Scholar
• Garzon R, Croce CM. MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol. 2008;15:352–358. doi: 10.1097/MOH.0b013e328303e15d
   PubMed Web of Science ®Google Scholar
• Yan W, Guo H, Suo F, et al. The effect of miR-146a on STAT1 expression and apoptosis in acute lymphoblastic leukemia Jurkat cells. Oncol Lett. 2017;13:151–154. doi: 10.3892/ol.2016.5395
   PubMed Web of Science ®Google Scholar
• Spinello I, Quaranta MT, Riccioni R, et al. MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias. Blood Cancer J. 2011;1:e26. doi: 10.1038/bcj.2011.24
   PubMed Web of Science ®Google Scholar
• Lin X, Wang Z, Zhang R, et al. High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia. Clin Transl Oncol. 2015;17:358–364. doi: 10.1007/s12094-014-1237-z
   PubMed Web of Science ®Google Scholar
• Verduci L, Azzalin G, Gioiosa S, et al. microRNA-181a enhances cell proliferation in acute lymphoblastic leukemia by targeting EGR1. Leuk Res. 2015;39:479–485. doi: 10.1016/j.leukres.2015.01.010
   PubMed Web of Science ®Google Scholar
• Su R, Lin HS, Zhang XH, et al. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets. Oncogene. 2015;34:3226–3239. doi: 10.1038/onc.2014.274
   PubMed Web of Science ®Google Scholar
• Weng H, Lal K, Yang FF, et al. The pathological role and prognostic impact of miR-181 in acute myeloid leukemia. Cancer Genet. 2015;208:225–229. doi: 10.1016/j.cancergen.2014.12.006
   PubMed Web of Science ®Google Scholar
• Dance GS, Beemiller P, Yang Y, et al. Identification of the yeast cytidine deaminase CDD1 as an orphan C–>U RNA editase. Nucleic Acids Res. 2001;29:1772–1780. doi: 10.1093/nar/29.8.1772
   PubMed Web of Science ®Google Scholar
• Kern L, de Montigny J, Jund R, et al. The FUR1 gene of Saccharomyces cerevisiae: cloning, structure and expression of wild-type and mutant alleles. Gene. 1990;88:149–157. doi: 10.1016/0378-1119(90)90026-N
   PubMed Web of Science ®Google Scholar
• Kurtz JE, Exinger F, Erbs P, et al. The URH1 uridine ribohydrolase of Saccharomyces cerevisiae. Curr Genet. 2002;41:132–141. doi: 10.1007/s00294-002-0296-9
   PubMed Web of Science ®Google Scholar
• Kurtz JE, Exinger F, Erbs P, et al. New insights into the pyrimidine salvage pathway of Saccharomyces cerevisiae: requirement of six genes for cytidine metabolism. Curr Genet. 1999;36:130–136. doi: 10.1007/s002940050482
   PubMed Web of Science ®Google Scholar
• Mitterbauer R, Weindorfer H, Safaie N, et al. A sensitive and inexpensive yeast bioassay for the mycotoxin zearalenone and other compounds with estrogenic activity. Appl Environ Microbiol. 2003;69:805–811. doi: 10.1128/AEM.69.2.805-811.2003
   PubMed Web of Science ®Google Scholar
• Shao J, Zhou B, Chu B, et al. Ribonucleotide reductase inhibitors and future drug design. Curr Cancer Drug Targets. 2006;6:409–431. doi: 10.2174/156800906777723949
   PubMed Web of Science ®Google Scholar
• Aimiuwu J, Wang H, Chen P, et al. RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia. Blood. 2012;119:5229–5238. doi: 10.1182/blood-2011-11-382226
   PubMed Web of Science ®Google Scholar
• Alharbi RA, Pettengell R, Pandha HS, et al. The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia. 2013;27:1000–1008. doi: 10.1038/leu.2012.356
   PubMed Web of Science ®Google Scholar
• Ferrando AA, Armstrong SA, Neuberg DS, et al. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood. 2003;102:262–268. doi: 10.1182/blood-2002-10-3221
   PubMed Web of Science ®Google Scholar
• Rozovskaia T, Feinstein E, Mor O, et al. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality. Oncogene. 2001;20:874–878. doi: 10.1038/sj.onc.1204174
   PubMed Web of Science ®Google Scholar